Xylem Inc (XYL)
Official siteINDUSTRIALS • SPECIALTY INDUSTRIAL MACHINERY • NYSE
Market Cap: $21.60B
Last updated: Nov 17, 2026 at 11:06 AM ET
Xylem Inc (XYL) Earnings: Report Dates and Results
Xylem (XYL) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Xylem reported EPS of $1.44, below the $1.47 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
XYL has an expected report date of Feb 8, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 0.7% above the $1.42 reported for the quarter ended Dec 31, 2025.
XYL Earnings Call
The latest XYL earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, XYL beat 29, missed 4 and matched 7. Revenue for the quarter ended Sep 30, 2026 was $2.20B, down 3.1% from $2.27B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.44 | $1.47 | $1.40 - $1.53 | -2.04% | Miss | +5.1% | 18 | 0 up, 1 down | Oct 27, 2026 | $2.20B |
| Jun 30, 2026 | $1.46 | $1.34 | $1.32 - $1.36 | +8.96% | Beat | +15.9% | 20 | 0 up, 1 down | Jul 28, 2026 | $2.34B |
| Mar 31, 2026 | $1.12 | $1.08 | $1.06 - $1.11 | +3.70% | Beat | +8.7% | 19 | 2 up, 5 down | Apr 28, 2026 | $2.13B |
| Dec 31, 2025 | $1.42 | $1.41 | $1.38 - $1.45 | +0.71% | Beat | +20.3% | 19 | 1 up, 4 down | Feb 10, 2026 | $2.40B |
| Sep 30, 2025 | $1.37 | $1.23 | $1.20 - $1.26 | +11.38% | Beat | +23.4% | 18 | 4 up, 1 down | Oct 28, 2025 | $2.27B |
| Jun 30, 2025 | $1.26 | $1.15 | $1.11 - $1.18 | +9.57% | Beat | +15.6% | 17 | 2 up, 2 down | Jul 31, 2025 | $2.30B |
| Mar 31, 2025 | $1.03 | $0.95 | $0.93 - $0.99 | +8.42% | Beat | +14.4% | 14 | 3 up, 1 down | Apr 29, 2025 | $2.07B |
| Dec 31, 2024 | $1.18 | $1.13 | $1.11 - $1.14 | +4.42% | Beat | +19.2% | 15 | 1 up, 5 down | Feb 4, 2025 | $2.26B |
| Sep 30, 2024 | $1.11 | $1.11 | $1.09 - $1.13 | 0.00% | In line | +12.1% | 15 | 3 up, 1 down | Oct 31, 2024 | $2.10B |
| Jun 30, 2024 | $1.09 | $1.05 | $1.03 - $1.09 | +3.81% | Beat | +11.2% | 14 | 1 up, 1 down | Jul 30, 2024 | $2.17B |
| Mar 31, 2024 | $0.90 | $0.84 | $0.82 - $0.87 | +7.14% | Beat | +25.0% | 14 | 3 up, 0 down | May 2, 2024 | $2.03B |
| Dec 31, 2023 | $0.99 | $0.95 | $0.92 - $1.00 | +4.21% | Beat | +7.6% | 14 | 1 up, 0 down | Feb 6, 2024 | $2.12B |
| Sep 30, 2023 | $0.99 | $0.89 | $0.86 - $0.92 | +11.24% | Beat | +25.3% | 13 | 1 up, 1 down | Oct 31, 2023 | $2.08B |
| Jun 30, 2023 | $0.98 | $0.81 | $0.61 - $0.91 | +20.99% | Beat | +48.5% | 9 | 0 up, 0 down | Aug 2, 2023 | $1.72B |
| Mar 31, 2023 | $0.72 | $0.62 | $0.58 - $0.65 | +16.13% | Beat | +53.2% | 12 | 0 up, 0 down | May 4, 2023 | $1.45B |
| Dec 31, 2022 | $0.92 | $0.79 | $0.76 - $0.82 | +16.46% | Beat | +46.0% | 14 | 3 up, 0 down | Feb 7, 2023 | $1.51B |
| Sep 30, 2022 | $0.79 | $0.66 | $0.61 - $0.68 | +19.70% | Beat | +25.4% | 16 | 0 up, 1 down | Nov 1, 2022 | $1.38B |
| Jun 30, 2022 | $0.66 | $0.54 | $0.51 - $0.57 | +22.22% | Beat | 0.0% | 17 | 1 up, 1 down | Aug 2, 2022 | $1.36B |
| Mar 31, 2022 | $0.47 | $0.43 | $0.38 - $0.45 | +9.30% | Beat | -16.1% | 16 | 0 up, 0 down | May 4, 2022 | $1.27B |
| Dec 31, 2021 | $0.63 | $0.61 | $0.55 - $0.65 | +3.28% | Beat | -22.2% | 16 | 0 up, 1 down | Feb 3, 2022 | $1.32B |
| Sep 30, 2021 | $0.63 | $0.60 | $0.55 - $0.65 | +5.00% | Beat | +1.6% | 15 | N/A | Nov 2, 2021 | $1.26B |
| Jun 30, 2021 | $0.66 | $0.63 | $0.59 - $0.68 | +4.76% | Beat | +65.0% | 16 | N/A | Aug 3, 2021 | $1.35B |
| Mar 31, 2021 | $0.56 | $0.37 | $0.35 - $0.40 | +51.35% | Beat | +143.5% | 17 | N/A | May 4, 2021 | $1.26B |
| Dec 31, 2020 | $0.81 | $0.68 | $0.62 - $0.73 | +19.12% | Beat | -9.0% | 16 | N/A | Feb 4, 2021 | $1.37B |
| Sep 30, 2020 | $0.62 | $0.50 | $0.38 - $0.56 | +24.00% | Beat | -24.4% | 15 | N/A | Oct 29, 2020 | $1.22B |
| Jun 30, 2020 | $0.40 | $0.38 | $0.38 - $0.39 | +5.26% | Beat | -49.4% | 10 | N/A | Jul 30, 2020 | $1.16B |
| Mar 31, 2020 | $0.23 | $0.37 | $0.28 - $0.47 | -37.84% | Miss | -55.8% | 15 | N/A | May 5, 2020 | $1.12B |
| Dec 31, 2019 | $0.89 | $0.89 | $0.88 - $0.90 | 0.00% | In line | +1.1% | 16 | N/A | Feb 6, 2020 | $1.37B |
| Sep 30, 2019 | $0.82 | $0.82 | $0.79 - $0.84 | 0.00% | In line | +6.5% | 15 | N/A | Oct 31, 2019 | $1.30B |
| Jun 30, 2019 | $0.79 | $0.79 | $0.76 - $0.80 | 0.00% | In line | +8.2% | 14 | N/A | Aug 1, 2019 | $1.34B |
| Mar 31, 2019 | $0.52 | $0.56 | $0.51 - $0.61 | -7.14% | Miss | +2.0% | 16 | N/A | May 2, 2019 | $1.24B |
| Dec 31, 2018 | $0.88 | $0.88 | $0.86 - $0.89 | 0.00% | In line | +15.8% | 16 | N/A | Jan 31, 2019 | $1.39B |
| Sep 30, 2018 | $0.77 | $0.77 | $0.75 - $0.80 | 0.00% | In line | +18.5% | 17 | N/A | Oct 30, 2018 | $1.29B |
| Jun 30, 2018 | $0.73 | $0.71 | $0.69 - $0.74 | +2.82% | Beat | +23.7% | 14 | N/A | Jul 31, 2018 | $1.32B |
| Mar 31, 2018 | $0.51 | $0.52 | $0.50 - $0.54 | -1.92% | Miss | +30.8% | 13 | N/A | May 1, 2018 | $1.22B |
| Dec 31, 2017 | $0.76 | $0.76 | $0.66 - $0.78 | 0.00% | In line | +15.2% | 15 | N/A | Feb 1, 2018 | $1.28B |
| Sep 30, 2017 | $0.65 | $0.64 | $0.62 - $0.66 | +1.56% | Beat | +20.4% | 13 | N/A | Oct 31, 2017 | $1.20B |
| Jun 30, 2017 | $0.59 | $0.57 | $0.54 - $0.58 | +3.51% | Beat | +22.9% | 14 | N/A | Aug 1, 2017 | $1.16B |
| Mar 31, 2017 | $0.39 | $0.38 | N/A | +2.63% | Beat | +11.4% | N/A | N/A | May 2, 2017 | $1.07B |
| Dec 31, 2016 | $0.66 | $0.65 | N/A | +1.54% | Beat | +10.0% | N/A | N/A | Feb 2, 2017 | $1.09B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $5.08, up 18.7% from the year before. It was $2.03 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $5.08 | +18.7% |
| Dec 31, 2024 | $4.28 | +16.3% |
| Dec 31, 2023 | $3.68 | +29.6% |
| Dec 31, 2022 | $2.84 | +14.5% |
| Dec 31, 2021 | $2.48 | +20.4% |
| Dec 31, 2020 | $2.06 | -31.8% |
| Dec 31, 2019 | $3.02 | +4.5% |
| Dec 31, 2018 | $2.89 | +20.9% |
| Dec 31, 2017 | $2.39 | +17.7% |
| Dec 31, 2016 | $2.03 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,000 words across 10 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,957 | 10 | |
| 2026Q2 | Jun 30, 2026 | 5,145 | 11 | |
| 2026Q1 | Mar 31, 2026 | 4,601 | 11 | |
| 2025Q4 | Dec 31, 2025 | 7,562 | 11 | |
| 2025Q3 | Sep 30, 2025 | 5,556 | 12 | |
| 2025Q2 | Jun 30, 2025 | 6,127 | 12 | |
| 2025Q1 | Mar 31, 2025 | 6,668 | 11 | |
| 2024Q4 | Dec 31, 2024 | 6,511 | 11 |
2026Q3 Earnings Call
Opening remarks
Gregory Giometti Senior Vice President, Investor Relations and FP&A Thank you, operator. Good morning, everyone, and welcome to Xylem's third quarter 2026 earnings call. With me today are Chief Executive Officer, Matthew Pine, and Chief Financial Officer, Andrea van der Berg. They will provide their perspectives on Xylem's third quarter results and discuss the fourth quarter and full year 2026 outlook. Following our prepared remarks, we will address questions related to the information covered on the call. I will ask that you please keep to one question and a follow-up, and then return to the queue. As a reminder, this call and our webcast are accompanied by a slide presentation available in the investors section of our website. A replay of today's call will be available until midnight November 10, and will be available for playback via the investors section of our website under the heading Investor Events. Please turn to Slide two. We will make some forward-looking statements on today's call, including references to future events or developments that we anticipate will or may occur in the future. These statements are subject to future risks and uncertainties, such as those factors described in Xylem's most recent annual report on Form 10-K and in subsequent reports filed with the SEC. Please note that the company undertakes no obligation to update any forward-looking statements publicly to reflect subsequent events or circumstances, and actual events or results could differ materially from those anticipated. Please turn to Slide three. We have provided you with a summary of our key performance metrics, including both GAAP and non-GAAP metrics. For the purposes of today's call, all references will be made on an organic and/or adjusted basis unless otherwise indicated, and non-GAAP financials have been reconciled for you and are included in the appendix section of the presentation. Now, please turn to Slide four, and I will turn the call over to our CEO, Matthew Pine.
Matthew Pine CEO Thank you, Greg, and good morning, everyone. Thank you for joining us. Before I begin, I'd like to welcome Andrea to her role as CFO of Xylem. Her deep knowledge of our business provides important continuity as we continue to execute our strategy. The third quarter reflected a mixed operating environment. Demand for Water Infrastructure and technology remains strong, which was evident in our order performance during the quarter. Across the markets we serve, the long-term drivers of water investment remain firmly in place. Near-term conditions were more challenging, with revenue coming in below our expectations as certain projects moved more slowly than anticipated and utility customer spending decisions took longer to materialize amid a more cautious and deliberate spending environment.
Frequently Asked Questions About XYL
When is Xylem's next earnings date?
Xylem's next earnings report is expected for Feb 8, 2027.
Did XYL beat earnings estimates last quarter?
No. Xylem reported EPS of $1.44 for the quarter ended Sep 30, 2026, below the $1.47 estimate by 2.04%.
What EPS do analysts expect from XYL next quarter?
The consensus EPS estimate for Xylem for the quarter ending Dec 31, 2026 is $1.43 from 19 analysts, with estimates from $1.31 to $1.53.
How often does XYL beat earnings estimates?
Xylem beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +5.64%.
XYL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts